Skip to main content
×
Home
    • Aa
    • Aa
  • Get access
    Check if you have access via personal or institutional login
  • Cited by 15
  • Cited by
    This article has been cited by the following publications. This list is generated based on data provided by CrossRef.

    Pocnet, Cornelia Antonietti, Jean-Philippe Donati, Alessia Popp, Julius Rossier, Jérôme and von Gunten, Armin 2015. Behavioral and psychological symptoms and cognitive decline in patients with amnestic MCI and mild AD: a two-year follow-up study. International Psychogeriatrics, Vol. 27, Issue. 08, p. 1379.


    Even, Christian and Weintraub, Daniel 2010. Case for and against specificity of depression in Alzheimer's disease. Psychiatry and Clinical Neurosciences, Vol. 64, Issue. 4, p. 358.


    Most, Els IS Scheltens, Philip and Van Someren, Eus JW 2010. Prevention of depression and sleep disturbances in elderly with memory-problems by activation of the biological clock with light - a randomized clinical trial. Trials, Vol. 11, Issue. 1,


    Delano-Wood, Lisa Houston, Wes S. Emond, Jennifer A. Marchant, Natalie L. Salmon, David P. Jeste, Dilip V. Thal, Leon J. and Bondi, Mark W. 2008. APOE genotype predicts depression in women with Alzheimer's disease: a retrospective study. International Journal of Geriatric Psychiatry, Vol. 23, Issue. 6, p. 632.


    Amore, M. Tagariello, P. Laterza, C. and Savoia, E.M. 2007. Subtypes of depression in dementia. Archives of Gerontology and Geriatrics, Vol. 44, p. 23.


    Anandatheerthavarada, Hindupur Κ. and Devi, Latha 2007. Mitochondrial Translocation of Amyloid Precursor Protein and its Cleaved Products: Relevance to Mitochondrial Dysfunction in Alzheimer's Disease. Reviews in the Neurosciences, Vol. 18, Issue. 5,


    Song, Li Che, Wang Min-wei, Wang Murakami, Yukihisa and Matsumoto, Kinzo 2006. Impairment of the spatial learning and memory induced by learned helplessness and chronic mild stress. Pharmacology Biochemistry and Behavior, Vol. 83, Issue. 2, p. 186.


    Craig, David Hart, Dominic J. McIlroy, Stephen P. and Passmore, A. Peter 2005. Association Analysis of Apolipoprotein E Genotype and Risk of Depressive Symptoms in Alzheimer’s Disease. Dementia and Geriatric Cognitive Disorders, Vol. 19, Issue. 2-3, p. 154.


    Urani, Alexandre Romieu, Pascal Roman, François J. Yamada, Kiyofumi Noda, Yukihiro Kamei, Hiroyuki Manh Tran, Hung Nagai, Taku Nabeshima, Toshitaka and Maurice, Tangui 2004. Enhanced antidepressant efficacy of σ1 receptor agonists in rats after chronic intracerebroventricular infusion of β-amyloid-(1–40) protein. European Journal of Pharmacology, Vol. 486, Issue. 2, p. 151.


    Finkel, Sanford I 2003. Behavioral and psychologic symptoms of dementia. Clinics in Geriatric Medicine, Vol. 19, Issue. 4, p. 799.


    Lee, Hochang B and Lyketsos, Constantine G 2003. Depression in Alzheimer’s disease: heterogeneity and related issues. Biological Psychiatry, Vol. 54, Issue. 3, p. 353.


    Alexopoulos, George S. Borson, Soo Cuthbert, Bruce N. Devanand, D.P. Mulsant, Benoit H. Olin, Jason T. and Oslin, David W. 2002. Assessment of late life depression. Biological Psychiatry, Vol. 52, Issue. 3, p. 164.


    Olin, Jason T. Katz, Ira R. Meyers, Barnett S. Schneider, Lon S. and Lebowitz, Barry D. 2002. Provisional Diagnostic Criteria for Depression of Alzheimer Disease: Rationale and Background. The American Journal of Geriatric Psychiatry, Vol. 10, Issue. 2, p. 129.


    2002. Current Awareness. International Journal of Geriatric Psychiatry, Vol. 17, Issue. 3, p. 297.


    Jorm, Anthony F. 2001. History of depression as a risk factor for dementia: an updated review. Australian and New Zealand Journal of Psychiatry, Vol. 35, Issue. 6, p. 776.


    ×

Neurobiology of Major Depression in Alzheimer's Disease

  • George S. Zubenko (a1) (a2)
  • DOI: http://dx.doi.org/10.1017/S1041610200007079
  • Published online: 01 July 2000
Abstract

The original catecholamine hypothesis of affective disorders focused largely on the role of the noradrenergic components of the central nervous system in the etiology of depression and mania (Bunney & Davis, 1965; Schildkraut, 1965). Additional evidence from clinical, pharmacologic, and physiologic studies has emerged since the original hypothesis was proposed and generally supports the view that clinically significant depression can result from a dysfunction of central nervous system mechanisms employing the catecholamine neurotransmitters norepinephrine and dopamine (Jimerson, 1987; Siever, 1987). Neurochemical studies of serotonin (5-HT) receptors and 5-hydroxyindoleacetic acid (5-HIAA) in spinal fluid or brain tissue also suggest an alteration in serotonergic components of the central nervous system in both idiopathic major depression and suicide (Brikmayer & Riederer, 1975; Crow et al., 1984; Lloyd et al., 1974; Mendlewicz et al., 1981; Stanley & Mann, 1983). In contrast to these hypotheses, which suggest that depression may result from the decreased function of one or more central aminergic systems, the cholinergic hypothesis of affective disorders (Janowsky & Risch, 1987) posits that idiopathic depression is associated with the hyperfunctioning of cholinergic systems. This hypothesis is especially interesting in the context of Alzheimer's disease (AD) because the progression of the central cholinergic deficit that occurs in this disorder may interact with the pathophysiology of depression to limit the prevalence of major depression in later stages of this disorder.

Copyright
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

International Psychogeriatrics
  • ISSN: 1041-6102
  • EISSN: 1741-203X
  • URL: /core/journals/international-psychogeriatrics
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×